Comprehensive Psychiatry
Volume 48, Issue 3 , Pages 264-268 , May 2007

Insight and psychopathology in never-treated schizophrenia

  • Srinivasan Tirupati

      Affiliations

    • Hunter Mental Health, The University of Newcastle, NSW 2300, Australia
    • Corresponding Author InformationCorresponding author. Hunter Mental Health, James Fletcher Hospital, PO Box 833, Newcastle 2300, Australia. Tel.: +61 408514837; fax: +61 2 49246527.
    • ,
  • Raman Padmavati

      Affiliations

    • Schizophrenia Research Foundation (India), Chennai 600101, India
    • ,
  • Rangaswamy Thara

      Affiliations

    • Schizophrenia Research Foundation (India), Chennai 600101, India
    • ,
  • Robin G. McCreadie

      Affiliations

    • Crichton Royal Hospital, Dumfries, DG1 4XB Scotland, UK

References 

  1. McGorry PD, McConville SB. Insight in psychosis: an elusive target. Compr Psychiatry. 1999;40:131–142
  2. David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798–808
  3. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51:826–836
  4. Schwartz RC, Skaggs JL, Petersen S. Critique of recent empirical research on insight and symptomatology in schizophrenia. Psychol Rep. 2000;86:471–474
  5. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br J Psychiatry. 1992;161:599–602
  6. Sevy S, Nathanson K, Visweswaraiah H, Amador X. The relationship between insight and symptoms in schizophrenia. Compr Psychiatry. 2004;45:16–19
  7. Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med. 2003;33:111–119
  8. Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophr Res. 2004;67:213–217
  9. Cuesta MJ, Peralta V, Zarzuela A. Reappraising insight in psychosis. Multi-scale longitudinal study. Br J Psychiatry. 2000;177:233–240
  10. McCreadie RG, Thara R, Kamath S, Padmavathy R, Latha S, Mathrubootham N, et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry. 1996;168:221–226
  11. McCreadie RG, Latha S, Thara R, Padmavathi R, Ayankaran JR. Poor memory, negative symptoms and abnormal movements in never treated Indian patients with schizophrenia. Br J Psychiatry. 1997;171:360–363
  12. McCreadie RG, Thara R, Padmavathi R, Srinivasan TN, Jaipurkar SD. Structural brain differences between never-treated patients with schizophrenia with and without dyskinesia, and normal subjects. Arch Gen Psychiatry. 2002;59:332–336
  13. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM IV). 4th ed.. Washington (DC): American Psychiatric Association; 1994;
  14. Kay SR, Fiszbein S, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:262–273
  15. Lysaker PH, Bell M. Insight and cognitive impairment in schizophrenia: performance on repeated administration of Wisconsin Card Sorting Test. J Nerv Ment Dis. 1994;182:656–660
  16. Sanz M, Constable G, Lopez-Ibor I, Kemp R, David A. A comparative study of insight scales and their relationship to psychopathological and clinical profiles. Psychol Med. 1998;28:437–446
  17. Goldberg RW, Green-Paden LD, Lehman AF, Gold JM. Correlates of insight in serious mental illness. J Nerv Ment Dis. 2001;189:137–145
  18. Padmavathi R, Rajkumar S, Srinivasan TN. Schizophrenic patients who were never treated—a study in an Indian urban community. Psychol Med. 1998;28:1113–1117
  19. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150:873–879
  20. David A, van Os J, Jones P, Harvey I, Foerster A, Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. Br J Psychiatry. 1995;167:621–628
  21. Collins AR, Remington GJ, Coulter K, Birkett K. Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res. 1997;27:37–44
  22. Kemp RA, Lambert TJR. Insight in schizophrenia and its relationship to psychopathology. Schizophr Res. 1995;18:21–28
  23. Carroll A, Fattah S, Clyde Z, Coffey I, Owens DG, Johnstone EC. Correlates of insight and insight change in schizophrenia. Schizophr Res. 1999;35:247–253
  24. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry. 2000;177:511–515
  25. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry. 2000;57:471–480
  26. Lysaker PH, Bell MD, Bryson G, Kaplan E. Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand. 1998;97:297–301
  27. Drake RJ, Lewis SW. Insight and neurocognition in schizophrenia. Schizophr Res. 2003;62:165–173
  28. Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X. Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. Int Clin Psychopharmacol. 2006;21:233–240
  29. McGorry PD. Psychoeducation in first episode psychosis: a therapeutic process. Psychiatry. 1995;58:313–328

PII: S0010-440X(06)00124-6

doi: 10.1016/j.comppsych.2006.10.006

Comprehensive Psychiatry
Volume 48, Issue 3 , Pages 264-268 , May 2007

Article Tools